Monitoring safety and use of old and new treatment options for type 2 diabetic patients: a two-year (2013

Monitoring safety and use of old and new treatment options for type 2 diabetic patients: a two-year (2013–2016) analysis

Published:2016-11-22 Issue:sup2 Volume:15 Page:17-34
ISSN:1474-0338
Container-title:Expert Opinion on Drug Safety
language:en
Short-container-title:Expert Opinion on Drug Safety

Author:

Leporini Christian¹,Piro Rosanna²,Ursini Francesco¹,Maida Francesca¹,Palleria Caterina¹,Arturi Franco³,Pavia Maria⁴,De Sarro Giovambattista¹,Russo Emilio¹

Affiliation:

1. School of Medicine and Surgery, Department of Health Sciences, Clinical Pharmacology and Pharmacovigilance Unit, ‘Magna Graecia’ University of Catanzaro, Catanzaro, Italy

2. ‘S Francesco di Paola’ Hospital, Diabetology and Metabolic Diseases Unit, Paola, Italy

3. Department of Medical and Surgical Sciences, Internal Medicine Unit of ‘Mater Domini’ University Hospital, ‘Magna Graecia’ University of Catanzaro, Catanzaro, Italy

4. Department of Health Sciences, Medical School, University of Catanzaro ‘Magna Græcia’, Campus of Germaneto, Catanzaro, Italy

Funder

Second University of Naples

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14740338.2016.1246531

Reference85 articles.

1. Pharmacoeconomics and Aging

2. Sixth Health Search report. 2010.